What kind of targeted drugs lung adenocarcinoma patients need to take depends on the results of patients’ genetic test, and the specific programs are as follows: 1. Those with EGFR gene mutation can take gefitinib, erlotinib, ectinib, afatinib, ositinib; 2. People with ALK gene mutation can take Crizotinib, Ceritinib, Aleitinib; 3. People with ROS gene mutation can take Crizotinib, Ceritinib; 4. People with c-MET gene mutation can take Crizotinib; 5. If adenocarcinoma patients do not have gene mutation, they can take Amlotinib. To summarize, what kind of targeted drugs should be taken by adenocarcinoma patients should be decided according to the results of patients’ genetic test. After diagnosis, patients should go to regular hospitals to receive treatment in time and do not use drugs by themselves.